Indevus' Supprelin LA Clears FDA As Once-Yearly Treatment For Premature Puberty
This article was originally published in The Pink Sheet Daily
Executive Summary
Implant for treatment of central precocious puberty will launch this summer, targeted to pediatric endocrinologists.